Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis

Journal of Autoimmunity

Volumn 77, Issue , 2017, Pages 45-54

  Chung, Brian K ^a,b,c,d   Guevel, Bardia T ^a,b   Reynolds, Gary M ^a,b   Gupta Udatha, D B R K ^c,e   Henriksen, Eva Kristine Klemsdal ^c,d,e   Stamataki, Zania ^a,b   Hirschfield, Gideon M ^a,b   Karlsen, Tom Hemming ^c,d,e   Liaskou, Evaggelia ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Birmingham Women s Hospital NHS Foundation Trust   (United Kingdom)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Antibody secreting B cells; Auto antibodies; Autoimmunity; Biomarkers; Primary biliary cholangitis; Primary sclerosing cholangitis; Protein arrays

Indexed keywords

ADENOSINE TRIPHOSPHATASE TYPE 13A5; ADHESION G PROTEIN COUPLED RECEPTOR A3; AUTOANTIBODY; CD19 ANTIGEN; CD20 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; HEMATOPOIETIC CELL SPECIFIC LYN SUBSTRATE 1; HEXOKINASE 1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTEGRIN BETA LIKE 1; KERATIN ASSOCIATED PROTEIN 5 4; MITOCHONDRION ANTIBODY; NUCLEOLAR PROTEIN 3; POTASSIUM CHANNEL TETRAMERIZATION DOMAIN CONTAINING 13; PRAME FAMILY MEMBER 12; PROLINE RICH COILED COIL 2B; PROTEIN; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATE DEHYDROGENASE COMPLEX E2; SERINE ARGININE RICH SPLICING FACTOR; SERINE ARGININE RICH SPLICING FACTOR 1; SYNDECAN 1; TEA DOMAIN FAMILY MEMBER 3; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BILE DUCT; CELL CULTURE; CELL INFILTRATION; CELL ISOLATION; CHOLANGITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER MONONUCLEAR CELL; LYMPHOCYTE; MALE; MONONUCLEAR CELL; PHENOTYPE; PLASMA CELL; PLASMABLAST; PORTAL VEIN; PRIMARY BILIARY CHOLANGITIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN MICROARRAY; SIGNAL NOISE RATIO; SUPERNATANT; AUTOIMMUNITY; BILIARY CIRRHOSIS; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; IMMUNOPHENOTYPING; LIVER; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; PATHOLOGY; SCLEROSING CHOLANGITIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODY FORMATION; ANTIGENS, CD20; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; BIOMARKERS; CHOLANGITIS, SCLEROSING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPHENOTYPING; LIVER; LIVER CIRRHOSIS, BILIARY; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PHENOTYPE; PLASMA CELLS; YOUNG ADULT;

EID: 85006054017     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2016.10.003     Document Type: Article

References (38)

1. [1] Norman, G.L., Yang, C.-Y., Ostendorff, H.P., Shums, Z., Lim, M.J., Wang, J., et al. Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis. Liver Int. 35 (2014), 642–651, 10.1111/liv.12690.
2. [2] Hu, C.J., Song, G., Huang, W., Liu, G.Z., Deng, C.W., Zeng, H.P., et al. Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays. Mol. Cell Proteomics 11 (2012), 669–680, 10.1074/mcp.M111.015529.
3. [3] Karlsen, T.H., Chung, B.K., Genetic risk and the development of autoimmune liver disease. Dig. Dis. 33:Suppl 2 (2015), 13–24, 10.1159/000440706.
4. [4] Hirschfield, G.M., Karlsen, T.H., Lindor, K.D., Adams, D.H., Primary sclerosing cholangitis. Lancet 382 (2013), 1587–1599, 10.1016/S0140-6736(13)60096-3.
5. [5] Hirschfield, G.M., Gershwin, M.E., The immunobiology and pathophysiology of primary biliary cirrhosis. Annu. Rev. Pathol. Mech. Dis. 8 (2013), 303–330, 10.1146/annurev-pathol-020712-164014.
6. [6] Hirschfield, G.M., Liu, X., Han, Y., Gorlov, I.P., Lu, Y., Xu, C., et al. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat. Publ. Group 42 (2010), 655–657, 10.1038/ng.631.
7. [7] Okada, Y., Kim, K., Han, B., Pillai, N.E., Ong, R.T.-H., Saw, W.-Y., et al. Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. Hum. Mol. Genet. 23 (2014), 6916–6926, 10.1093/hmg/ddu387.
8. [8] Hov, J.R., Boberg, K.M., Karlsen, T.H., Autoantibodies in primary sclerosing cholangitis. World J. Gastroenterol. 14 (2008), 3781–3791.
9. [9] Melum, E., Franke, A., Schramm, C., Weismüller, T.J., Gotthardt, D.N., Offner, F.A., et al. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat. Publ. Group 43 (2011), 17–19, 10.1038/ng.728.
10. [10] Liu, J.Z., Hov, J.R., Folseraas, T., Ellinghaus, E., Rushbrook, S.M., Doncheva, N.T., et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat. Publ. Group 45 (2013), 670–675, 10.1038/ng.2616.
11. [11] Karlsen, T.H., Franke, A., Melum, E., Kaser, A., Hov, J.R., Balschun, T., et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 138 (2010), 1102–1111, 10.1053/j.gastro.2009.11.046.
12. [12] Cabibi, D., Tarantino, G., Barbaria, F., Campione, M., Craxì, A., Di Marco, V., Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. Dig. Liver Dis. 42 (2010), 585–592, 10.1016/j.dld.2009.12.006.
13. [13] Moreira, R.K., Revetta, F., Koehler, E., Washington, M.K., Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease. World J. Gastroenterol. 16 (2010), 453–457.
14. [14] Myers, R.P., Swain, M.G., Lee, S.S., Shaheen, A.A.M., Burak, K.W., B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid. Am. J. Gastroenterol. 108 (2013), 933–941, 10.1038/ajg.2013.51.
15. [15] Suwannalai, P., Scherer, H.U., van der Woude, D., Ioan-Facsinay, A., Jol-van der Zijde, C.M., van Tol, M.J.D., et al. Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens. Ann. Rheum. Dis. 70 (2011), 373–379, 10.1136/ard.2010.135509.
16. [16] Huang, H., Benoist, C., Mathis, D., Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis. Proc. Natl. Acad. Sci. 107 (2010), 4658–4663, 10.1073/pnas.1001074107.
17. [17] Reynolds, G.M., Billingham, L.J., Gray, L.J., Flavell, J.R., Najafipour, S., Crocker, J., et al. Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of ‘B’ symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease. Br. J. Haematol. 118 (2002), 195–201.
18. [18] Saha, K., Case, R., Wong, P.K., A simple method of concentrating monoclonal antibodies from culture supernatant by ultrafiltration. J. Immunol. Methods 151 (1992), 307–308.
19. [19] Farci, P., Diaz, G., Chen, Z., Govindarajan, S., Tice, A., Agulto, L., et al. B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure. Proc. Natl. Acad. Sci. 107 (2010), 8766–8771, 10.1073/pnas.1003854107.
20. [20] Mesin, L., Di Niro, R., Thompson, K.M., Lundin, K.E.A., Sollid, L.M., Long-lived plasma cells from human small intestine biopsies secrete immunoglobulins for many weeks in vitro. J. Immunol. 187 (2011), 2867–2874, 10.4049/jimmunol.1003181.
21. [21] Kaminski, D.A., Wei, C., Qian, Y., Rosenberg, A.F., Sanz, I., Advances in human B cell phenotypic profiling. Front. Immunol., 3, 2012, 302, 10.3389/fimmu.2012.00302.
22. [22] Cocco, M., Stephenson, S., Care, M.A., Newton, D., Barnes, N.A., Davison, A., et al. In vitro generation of long-lived human plasma cells. J. Immunol. 189 (2012), 5773–5785, 10.4049/jimmunol.1103720.
23. [23] Jeong, J.S., Jiang, L., Albino, E., Marrero, J., Rho, H.S., Hu, J., et al. Rapid identification of monospecific monoclonal antibodies using a human proteome microarray. O111.016253 Mol. Cell Proteomics, 11, 2012, 10.1074/mcp.O111.016253.
24. [24] Nutt, S.L., Hodgkin, P.D., Tarlinton, D.M., Corcoran, L.M., The generation of antibody-secreting plasma cells. Nat. Rev. Immunol. 15 (2015), 160–171, 10.1038/nri3795.
25. [25] Zhang, J., Zhang, W., Leung, P.S.C., Bowlus, C.L., Dhaliwal, S., Coppel, R.L., et al. Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology 60 (2014), 1708–1716, 10.1002/hep.27313.
26. [26] Soro, P.G., Morales-A, P., Martínez-M, J.A., Morales-A, S., Copín, S.G., Marcos, M.A., et al. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells. J. Immunol. 163 (1999), 611–617.
27. [27] Angelin-Duclos, C., Cattoretti, G., Lin, K.I., Calame, K., Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. J. Immunol. 165 (2000), 5462–5471.
28. [28] Kallies, A., Hasbold, J., Tarlinton, D.M., Dietrich, W., Corcoran, L.M., Hodgkin, P.D., et al. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J. Exp. Med. 200 (2004), 967–977, 10.1084/jem.20040973.
29. [29] Eksteen, B., The gut-liver Axis in primary sclerosing cholangitis. Clin. Liver Dis. 20 (2016), 1–14, 10.1016/j.cld.2015.08.012.
30. [30] Kummen, M., Holm, K., Anmarkrud, J.A., Nygård, S., Vesterhus, M., Høivik, M.L., et al. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls. Gut, 2016, 10.1136/gutjnl-2015-310500.
31. [31] Quraishi, M.N., Sergeant, M., Kay, G., Iqbal, T., Chan, J., Constantinidou, C., et al. The gut-adherent microbiota of PSC–IBD is distinct to that of IBD. gutjnl–2016–311915 Gut, 2016, 10.1136/gutjnl-2016-311915.
32. [32] Heydtmann, M., Lalor, P.F., Eksteen, J.A., Hübscher, S.G., Briskin, M., Adams, D.H., CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J. Immunol. 174 (2005), 1055–1062.
33. [33] Oo, Y.H., Banz, V., Kavanagh, D., Liaskou, E., Withers, D.R., Humphreys, E., et al. CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver. J. Hepatol. 57 (2012), 1044–1051, 10.1016/j.jhep.2012.07.008.
34. [34] Berglin, L., Björkström, N.K., Bergquist, A., Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cells. Scand. J. Gastroenterol. 48 (2015), 719–728, 10.3109/00365521.2013.786131.
35. [35] Liaskou, E., Henriksen, E.K.K., Holm, K., Kaveh, F., Hamm, D., Fear, J., et al. High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires. Hepatology, 2015, 10.1002/hep.28116.
36. [36] Uhlén, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., et al. Towards a knowledge-based human protein atlas. Nat. Biotechnol. 28 (2010), 1248–1250, 10.1038/nbt1210-1248.
37. [37] Uhlén, M., Fagerberg, L., Hallström, B.M., Lindskog, C., Oksvold, P., Mardinoglu, A., et al. Proteomics. Tissue-based map of the human proteome. Science, 347, 2015, 1260419, 10.1126/science.1260419.
38. [38] Wang, M., Qanungo, S., Crow, M.T., Watanabe, M., Nieminen, A.-L., Apoptosis repressor with caspase recruitment domain (ARC) is expressed in cancer cells and localizes to nuclei. FEBS Lett. 579 (2005), 2411–2415, 10.1016/j.febslet.2005.03.040.